Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu

Study of Pomaglumetad and Methamphetamine (POMA-MA-Ph1)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03106571
Recruitment Status : Recruiting
First Posted : April 10, 2017
Last Update Posted : June 19, 2018
Sponsor:
Collaborator:
National Institute on Drug Abuse (NIDA)
Information provided by (Responsible Party):
Keith Heinzerling, University of California, Los Angeles

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Recruiting
  Estimated Primary Completion Date : May 2019
  Estimated Study Completion Date : December 2019